Literature DB >> 21604966

Ameliorative effect of thymoquinone on ovalbumin-induced allergic conjunctivitis in Balb/c mice.

Khizar Hayat1, M B Raza Asim, Muhammad Nawaz, Miao Li, Lin Zhang, Naixue Sun.   

Abstract

OBJECTIVE: Thymoquinone (TQ) is an active and potent compound in the oil of Nigella sativa, which has anti-inflammatory properties. The aim of this study was to evaluate the effects of TQ on ovalbumin (OVA)-induced allergic conjunctivitis (AC) in Balb/c.
METHODS: The mice were divided into seven experimental groups; PBS Con, OVA Con, Conj, 0.05%TQ, 0.1%TQ, 0.5%TQ and Dex group. The mice were immunized and exposed to OVA, and eyes were treated with TQ and dexamethasone. Ocular symptoms were observed after last exposure to OVA. Eosinophils count in blood and Ophthalmic lavage fluid (OLF), recruitment of inflammatory cells in conjunctiva, serum IgE and OVA-specific IgE were evaluated by Giemsa and HE staining, and Enzyme-Linked Immunosorbent Assay (ELISA) respectively. High Performance Liquid Chromatography (HPLC) was used to determine the histamine level in OLF. The mRNA expression and protein level of cytokines were examined by real time RT-PCR and ELISA respectively.
RESULTS: Ocular symptoms of AC and other characteristics of allergic inflammation including IgE and OVA-specific immunoglobulin E (IgE) level, recruitment of eosinophils, histamine level, mRNA expressions and protein level of cytokines were remarkably increased in OVA-exposed mice compared with the control groups. Administration of TQ suppressed the ocular symptoms, inflammatory cell infiltration in conjunctiva, blood and OLF, increased level of serum IgE and OVA-specific IgE, and OLF histamine level in OVA-exposed mice. Furthermore, TQ abrogated the mRNA expression and serum level of interleukin including 1L-4, IL-5, IL-13 and transforming growth factor beta (TGF-β) in mice immunized and exposed to OVA.
CONCLUSION: Administration of TQ significantly reduced the ocular symptoms in AC by attenuating the recruitment of eosinophils, level of IgE, histamine and cytokines. Our findings suggest that TQ might be a useful intimation for the treatment and future research for AC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21604966     DOI: 10.3109/02713683.2011.573898

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

1.  The Role of Topical Thymoquinone in the Treatment of Acute Otitis Externa; an Experimental Study in Rats.

Authors:  Hasan Demirel; Cengiz Arlı; Tümay Özgür; Melek İnci; Recep Dokuyucu
Journal:  J Int Adv Otol       Date:  2018-08       Impact factor: 1.017

Review 2.  Ocular redness - II: Progress in development of therapeutics for the management of conjunctival hyperemia.

Authors:  Rohan Bir Singh; Lingjia Liu; Ann Yung; Sonia Anchouche; Sharad K Mittal; Tomas Blanco; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2021-05-15       Impact factor: 6.268

3.  THE SERUM PROTEIN FRACTIONS IN THYMOQUINONE TREATED RATS.

Authors:  Güllü A; Dede S
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-09-29

Review 4.  Thymoquinone in Ocular Neurodegeneration: Modulation of Pathological Mechanisms via Multiple Pathways.

Authors:  Nur Musfirah Mahmud; Luminita Paraoan; Nurliza Khaliddin; Tengku Ain Kamalden
Journal:  Front Cell Neurosci       Date:  2022-03-02       Impact factor: 5.505

5.  Oleanolic acid controls allergic and inflammatory responses in experimental allergic conjunctivitis.

Authors:  Claudia Córdova; Beatriz Gutiérrez; Carmen Martínez-García; Rubén Martín; Patricia Gallego-Muñoz; Marita Hernández; María L Nieto
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240

Review 6.  Chronic diseases, inflammation, and spices: how are they linked?

Authors:  Ajaikumar B Kunnumakkara; Bethsebie L Sailo; Kishore Banik; Choudhary Harsha; Sahdeo Prasad; Subash Chandra Gupta; Alok Chandra Bharti; Bharat B Aggarwal
Journal:  J Transl Med       Date:  2018-01-25       Impact factor: 5.531

7.  Preparation of Liposomal Formulations for Ocular Delivery of Thymoquinone: In Vitro Evaluation in HCEC-2 e HConEC Cells.

Authors:  Elisa Landucci; Francesca Bonomolo; Chiara De Stefani; Costanza Mazzantini; Domenico Edoardo Pellegrini-Giampietro; Anna Rita Bilia; Maria Camilla Bergonzi
Journal:  Pharmaceutics       Date:  2021-12-05       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.